Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults
Clinical trial NCT01574638 · COMPLETED
Trial details
- NCT number
- NCT01574638
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-06-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.